D-1038-2014 Class II Terminated

Recalled by The Mentholatum Co. — Orchard Park, NY

FDA drug recall D-1038-2014 was initiated by The Mentholatum Co. on Jan 16, 2014 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of… The recall status is terminated (terminated Jun 1, 2018). Affected quantity: 94,080 units Total (432 units held in stock, quarantined).

Recall details

Product Type
Drugs
Report Date
Feb 5, 2014
Initiation Date
Jan 16, 2014
Termination Date
Jun 1, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
94,080 units Total (432 units held in stock, quarantined)

Product description

ROHTO Redness Relief, ice, Redness Reliever, Lubricant, Astringent Eye Drops, Sterile, Net. Wt. 0.4 FL OZ (13 mL). UPC 3 10742 01086 2, Manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. for The Mentholatum Company, Orchard Park, NY 14127. Made in Vietnam.

Reason for recall

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Distribution pattern

Nationwide and Puerto Rico

Code information

Stock No: 1086; Case UPC: 3 10742 91086 (5); Item UPC 3 10742 01086 2

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1038-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1038-2014. Report a data issue: hello@regdatalab.com.